Ho Maykin Insider Trades

Insider Trading History

Track insider trading activity for Ho Maykin. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Neumora Therapeutics
Neumora Therapeutics NMRA
Director
Holding Value $139k 80,000 shares
Last Trade
May 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$149k 80,000 shares
$1.86
$1.74
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $0 0 shares
Last Trade
Jun 20, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$72.9k 2,120 shares
$34.41
$27.68
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $471k 17,032 shares
Last Trade
Jun 20, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$72.9k 2,120 shares
$34.41
$27.68
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $436k 15,768 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$560k 15,768 shares
$35.50
$27.68
FibroGen
FibroGen FGEN
Director
Holding Value $1.09M 120,000 shares
Last Trade
Jun 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$916k 120,000 shares
$7.63
$9.07
Neumora Therapeutics
Neumora Therapeutics NMRA
Director
Holding Value $166k 95,586 shares
Last Trade
May 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$167k 231,959 shares
$0.72
$1.74
Neumora Therapeutics
Neumora Therapeutics NMRA
Director
Holding Value $0 0 shares
Last Trade
May 28, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$20.4k 28,571 shares
$0.72
$1.74
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Director
Holding Value $1.53M 28,010 shares
Last Trade
May 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$399k 6,650 shares
$59.93
$54.66
Neumora Therapeutics
Neumora Therapeutics NMRA
Director
Holding Value $0 0 shares
Last Trade
Feb 13, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$257k 151,959 shares
$1.69
$1.74
Neumora Therapeutics
Neumora Therapeutics NMRA
Director
Holding Value $166k 95,586 shares
Last Trade
Feb 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$257k 151,959 shares
$1.69
$1.74
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $326k 11,774 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$500k 11,774 shares
$42.45
$27.68
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $0 0 shares
Last Trade
Jun 13, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$158k 3,388 shares
$46.77
$27.68
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $413k 14,912 shares
Last Trade
Jun 13, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$158k 3,388 shares
$46.77
$27.68
FibroGen
FibroGen FGEN
Director
Holding Value $635k 70,000 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.12M 70,000 shares
$30.25
$9.07
Biomarin Pharmaceutical - Registered Shares
Biomarin Pharmaceutical - Registered Shares BMRN
Director
Holding Value $1.17M 21,360 shares
Last Trade
May 21, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$365k 4,720 shares
$77.34
$54.66
Neumora Therapeutics
Neumora Therapeutics NMRA
Director
Holding Value $48.4k 27,802 shares
Last Trade
Sep 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$1.74
Neumora Therapeutics
Neumora Therapeutics NMRA
Director
Holding Value $0 0 shares
Last Trade
Sep 14, 2023 Sale
No data
No data
$1.74
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $0 0 shares
Last Trade
Jun 21, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$134k 4,975 shares
$26.98
$27.68
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $319k 11,524 shares
Last Trade
Jun 21, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$134k 4,975 shares
$26.98
$27.68
Agios Pharmaceuticals
Agios Pharmaceuticals AGIO
Director
Holding Value $525k 18,958 shares
Last Trade
Jun 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$504k 18,958 shares
$26.56
$27.68

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up